thanks,
but I'm not sure what a discursive sensitivity analysis is hahaha.
I also think the hernia stuff will be huge with all the law suits against Johnson and Johnson for the alternative products.
I just see it as needing some time to prove that they work as well in terms of actually preventing a repeat hernia through the same area. I am a little bit shady on how this might work with the biodegradable synthetic.
does anyone have any information on how the PNV hernia product is supposed to work in comparison to what's on the market at the moment.
I think I understand the burns and ulcer stuff well but can't get my head around how the hernia product will work?
Addressable Market, page-8
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.59 |
Change
0.220(9.28%) |
Mkt cap ! $1.787B | |||
| Open | High | Low | Value | Volume |
| $2.44 | $2.62 | $2.44 | $11.81M | 4.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 8020 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.59 | 48292 | 7 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |